Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Tipo de estudio
Intervalo de año de publicación
1.
Biochemistry ; 61(18): 1974-1987, 2022 09 20.
Artículo en Inglés | MEDLINE | ID: mdl-36070615

RESUMEN

Human lysine methyltransferase 2D (hKMT2D) is an epigenetic writer catalyzing the methylation of histone 3 lysine 4. hKMT2D by itself has little catalytic activity and reaches full activation as part of the WRAD2 complex, additionally comprising binding partners WDR5, RbBP5, Ash2L, and DPY30. Here, a detailed mechanistic study of the hKMT2D SET domain and its WRAD2 interactions is described. We characterized the WRAD2 subcomplexes containing full-length components and the hKMT2D SET domain. By performing steady-state analysis as a function of WRAD2 concentration, we identified the inner stoichiometry and determined the binding affinities for complex formation. Ash2L and RbBP5 were identified as the binding partners critical for the full catalytic activity of the SET domain. Contrary to a previous report, product and dead-end inhibitor studies identified hKMT2D as a rapid equilibrium random Bi-Bi mechanism with EAP and EBQ dead-end complexes. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-ToF MS) analysis showed that hKMT2D uses a distributive mechanism and gives further insights into how the WRAD2 components affect mono-, di-, and trimethylation. We also conclude that the Win motif of hKMT2D is not essential in complex formation, unlike other hKMT2 proteins.


Asunto(s)
N-Metiltransferasa de Histona-Lisina , Lisina , N-Metiltransferasa de Histona-Lisina/química , Histonas/metabolismo , Humanos , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Cinética , Lisina/metabolismo , Metilación , Proteína de la Leucemia Mieloide-Linfoide/química
2.
Biochemistry ; 59(50): 4775-4786, 2020 12 22.
Artículo en Inglés | MEDLINE | ID: mdl-33274632

RESUMEN

Protein arginine methyltransferases (PRMTs) are of great interest for the development of therapeutics due to their involvement in a number of malignancies, such as lung and colon cancer. PRMT5 catalyzes the formation of symmetrical dimethylarginine of a wide variety of substrates and is responsible for the majority of this mark within cells. To gain insight into the mechanism of PRMT5 inhibition, we co-expressed the human PRMT5:MEP50 complex (hPRMT5:MEP50) in insect cells for a detailed mechanistic study. In this report, we carry out steady state, product, and dead-end inhibitor studies that show hPRMT5:MEP50 uses a rapid equilibrium random order mechanism with EAP and EBQ dead-end complexes. We also provide evidence of ternary complex formation in solution using hydrogen/deuterium exchange mass spectrometry. Isotope exchange and intact protein mass spectrometry further rule out ping-pong as a potential enzyme mechanism, and finally, we show that PRMT5 exhibits a pre-steady state burst that corresponds to an initial slow turnover with all four active sites of the hetero-octamer being catalytically active.


Asunto(s)
Proteína-Arginina N-Metiltransferasas/química , Proteína-Arginina N-Metiltransferasas/metabolismo , Proteínas Adaptadoras Transductoras de Señales/química , Proteínas Adaptadoras Transductoras de Señales/genética , Proteínas Adaptadoras Transductoras de Señales/metabolismo , Secuencia de Aminoácidos , Dominio Catalítico , Medición de Intercambio de Deuterio , Inhibidores Enzimáticos/farmacología , Humanos , Técnicas In Vitro , Cinética , Espectrometría de Masas , Modelos Moleculares , Dominios y Motivos de Interacción de Proteínas , Estructura Cuaternaria de Proteína , Proteína-Arginina N-Metiltransferasas/genética , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Especificidad por Sustrato
3.
Biochim Biophys Acta ; 1850(1): 13-21, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25277548

RESUMEN

BACKGROUND: Mycobacterium tuberculosis is a pathogenic prokaryote adapted to survive in hostile environments. In this organism and other Gram-positive actinobacteria, the metabolic pathways of glycogen and trehalose are interconnected. RESULTS: In this work we show the production, purification and characterization of recombinant enzymes involved in the partitioning of glucose-1-phosphate between glycogen and trehalose in M. tuberculosis H37Rv, namely: ADP-glucose pyrophosphorylase, glycogen synthase, UDP-glucose pyrophosphorylase and trehalose-6-phosphate synthase. The substrate specificity, kinetic parameters and allosteric regulation of each enzyme were determined. ADP-glucose pyrophosphorylase was highly specific for ADP-glucose while trehalose-6-phosphate synthase used not only ADP-glucose but also UDP-glucose, albeit to a lesser extent. ADP-glucose pyrophosphorylase was allosterically activated primarily by phosphoenolpyruvate and glucose-6-phosphate, while the activity of trehalose-6-phosphate synthase was increased up to 2-fold by fructose-6-phosphate. None of the other two enzymes tested exhibited allosteric regulation. CONCLUSIONS: Results give information about how the glucose-1-phosphate/ADP-glucose node is controlled after kinetic and regulatory properties of key enzymes for mycobacteria metabolism. GENERAL SIGNIFICANCE: This work increases our understanding of oligo and polysaccharides metabolism in M. tuberculosis and reinforces the importance of the interconnection between glycogen and trehalose biosynthesis in this human pathogen.


Asunto(s)
Glucofosfatos/metabolismo , Glucógeno/biosíntesis , Redes y Vías Metabólicas , Mycobacterium tuberculosis/metabolismo , Trehalosa/biosíntesis , Regulación Alostérica , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Glucosa-1-Fosfato Adenililtransferasa/genética , Glucosa-1-Fosfato Adenililtransferasa/metabolismo , Glucosa-6-Fosfato/metabolismo , Glucosiltransferasas/genética , Glucosiltransferasas/metabolismo , Glucógeno Sintasa/genética , Glucógeno Sintasa/metabolismo , Cinética , Modelos Biológicos , Mycobacterium tuberculosis/enzimología , Proteínas Recombinantes/metabolismo , Especificidad por Sustrato , UTP-Glucosa-1-Fosfato Uridililtransferasa/genética , UTP-Glucosa-1-Fosfato Uridililtransferasa/metabolismo
4.
Chem Biol ; 12(1): 89-97, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15664518

RESUMEN

Using calmodulin antagonism as a model, it is demonstrated that, under circumstances in which binding sites are motionally independent, it is possible to create bifunctional ligands that bind with significant affinity enhancement over their monofunctional counterparts. Suitable head groups were identified by using a semiquantitative screen of monofunctional tryptophan analogs. Two bifunctional ligands, which contained two copies of the highest-affinity head group tethered by rigid linkers, were synthesized. The bifunctional ligands bound to calmodulin with a stoichiometry of 1:1 and with an affinity enhancement over their monofunctional counterparts; the latter bound with a stoichiometry of 2:1 ligand:protein. A lower limit to the effective concentrations of the domains of calmodulin relative to each other (0.2-2 mM) was determined. A comparable effective concentration was achieved for bifunctional ligands based on higher-affinity naphthalene sulphonamide derivatives.


Asunto(s)
Calmodulina/antagonistas & inhibidores , Movimiento/fisiología , Receptores Sensibles al Calcio/metabolismo , Triptófano/farmacología , Animales , Sitios de Unión , Unión Competitiva/efectos de los fármacos , Calmodulina/química , Ligandos , Imitación Molecular , Estructura Molecular , Movimiento/efectos de los fármacos , Naftalenos/farmacología , Péptidos/farmacología , Estructura Secundaria de Proteína , Receptores Sensibles al Calcio/efectos de los fármacos , Sulfonamidas/farmacología , Triptaminas/síntesis química , Triptaminas/farmacología , Triptófano/análogos & derivados , Triptófano/síntesis química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA